A special category is men in high-risk groups (e.g., African Americans, positive family history of prostate cancer or multiple malignancies in the family, positive testing for BRCA1 and BRCA2 mutations), where PSA testing is recommended starting at age 40 years. This evidence concerns the gene KLK3 and prostate carcinoma.